Haemonetics appoints James D'Arecca as CFO effective April 11, 2022; Burke to retire

HAEMONETICS CORP

James D'Arecca appointed CFO effective April 11, 2022; William Burke steps down as CFO on that date.
D'Arecca previously CFO at TherapeuticsMD; prior roles at Allergan, Bausch & Lomb, Merck, PwC.
Compensation: $525k base salary, 75% target bonus, $1.1M LTI target, $400k sign-on bonus.
Initial equity grant valued at $600k: 50% RSUs, 50% options, vesting 25% annually over 4 years.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James C. D'Arecca

Chief Financial Officer

HAE · HAEMONETICS CORP

Effective: 2022-04-11
Filed: March 21, 2022, 7:59 PM ET

On March 21, 2022, the Company announced the appointment of James C. D’Arecca as its Chief Financial Officer, effective April 11, 2022.

Departed

William P. Burke

Chief Financial Officer

HAE · HAEMONETICS CORP

Effective: 2022-04-11
Successor: James C. D'Arecca
Filed: March 21, 2022, 7:59 PM ET

Mr. Burke will step down as Chief Financial Officer and principal financial officer of the Company on April 11, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James C. D'Arecca was appointed as Chief Financial Officer at HAEMONETICS CORP.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On March 21, 2022, the Company announced the appointment of James C. D’Arecca as its Chief Financial Officer, effective April 11, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

William P. Burke retired as Chief Financial Officer at HAEMONETICS CORP.

Action: retired
Role: Chief Financial Officer

Exact text from the filing

Mr. Burke will step down as Chief Financial Officer and principal financial officer of the Company on April 11, 2022

View on SEC.gov

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-22-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.